Galangin ameliorated pulmonary fibrosis in vivo and in vitro by regulating epithelial-mesenchymal transition.

导出原文传递

翻译打印收藏纠错

作者： Liqun,Wang ^[1] ; Hongyao,Liu ^[2] ; Qiurong,He ^[3] ; Cailing,Gan ^[2] ; Yali,Li ^[1] ; Qianyu,Zhang ^[1] ; Yuqin,Yao ^[4] ; Fang,He ^[1] ; Tinghong,Ye ^[5] ; Wenya,Yin ^[6]

作者单位： West China School of Public Health and Healthy Food Evaluation Research Center and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. ^[1] Laboratory of Liver Surgery, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China. ^[2] West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. ^[3] West China School of Public Health and Healthy Food Evaluation Research Center and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address: yuqin_yao@scu.edu.cn. ^[4] Laboratory of Liver Surgery, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China. Electronic address: yeth1309@scu.edu.cn. ^[5] West China School of Public Health and Healthy Food Evaluation Research Center and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address: yinwenya@scu.edu.cn. ^[6]

关键词 Epithelial-mesenchymal transition (EMT)Galangin Inflammation Pulmonary fibrosis TGF-β1